Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AKBA will rise by +6.08% over the next 2 Weeks and hit $1.29 by Friday, August 7, 2026. In that time frame, AKBA's share price is expected to range between $1.22 and $1.38.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 7, 2026 | 1.17 | 1.24 | 1.32 |
| Aug 6, 2026 | 1.16 | 1.23 | 1.31 |
| Aug 5, 2026 | 1.13 | 1.21 | 1.29 |
| Aug 4, 2026 | 1.13 | 1.22 | 1.30 |
| Aug 3, 2026 | 1.12 | 1.20 | 1.28 |
| Jul 31, 2026 | 1.15 | 1.23 | 1.31 |
| Jul 30, 2026 | 1.14 | 1.22 | 1.30 |
| Jul 29, 2026 | 1.13 | 1.20 | 1.28 |
| Jul 28, 2026 | 1.13 | 1.20 | 1.28 |
| Jul 27, 2026 | 1.11 | 1.19 | 1.27 |
AKBA shares rose +4.92% in Monday, July 27, 2026's trading session, rising from a previous close of $1.22 to move at $1.28. The stock demonstrated notable intraday movement (see AKBA's key stats for a full breakdown), fluctuating between $1.24 and $1.30, a +4.84% trading range. While recent weeks have seen some volatility, AKBA has managed to secure a -8.57% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.86M shares changing hands, 362.18K more than the previous session. This amounted to $2.38M in total market activity.
Will AKBA Continue Its Upward Trend?
According to analyst ratings and projections for AKBA, Akebia Therapeutics, Inc. shares are anticipated to increase by +3.19%, potentially reaching $1.32 per share by August 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for AKBA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the AKBA stock forecast, now is a good time to buy AKBA stock because its current trading price is +2.93% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AKBA covering social and institutional perspectives.
AKBA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AKBA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.97% to 53.86%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.82%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.41%, maintains a neutral outlook for the long term. Insights into AKBA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Akebia Therapeutics Short-Term Forecasts
AKBA Forecast For Next 5 Days
Our algorithm anticipates Akebia Therapeutics (AKBA) stock could hit $1.45 by Aug 03, 2026. This represents a +13.43% fall from today's price, following a -4.29% change over the past five days.
AKBA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Akebia Therapeutics, Inc. (AKBA) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $1.38, which would mean a +7.81% increase from the current price of $1.28. Projections for this period range from a high of $1.69 to a low of $1.00.
AKBA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Akebia Therapeutics's price over the next three months point to a rise. AKBA stock is expected to peak at $7.46 on Jul 28, 2026 before potentially dipping to $5.08 on Oct 12, 2026. On average, AKBA is likely to trade around $6.48 in the coming 90 days.
Akebia Therapeutics Stock Forecast 2025
Based on our predictive models, Akebia Therapeutics (AKBA) is expected to trade between $2.78 and $7.46 throughout 2026. This would result in an average price of $6.07, potentially offering investors a +374.22% return from current levels.
Akebia Therapeutics, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Akebia Therapeutics, Inc. (AKBA) is positioned to show a strong performance in July 2026. The price is predicted to move between $7.26 and $7.46, settling at an average of $7.37. This could translate to a +475.78% gain.
August 2026
Based on current market signals, Akebia Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $6.17 to $7.28, with a likely average price of $6.77. Investors could expect a potential return of +428.91%.
September 2026
Our predictive algorithms indicate Akebia Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $5.71–$6.96, with an average target of $6.54. This represents a positive outlook and a possible gain of +410.94%.
October 2026
Analyzing established trends, Akebia Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $4.82 and $6.02, averaging around $5.85. This suggests a +357.03% gain from current levels.
November 2026
Market indicators suggest Akebia Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $3.97 to $5.59, with a midpoint forecast of $5.37. The stock might deliver a +319.53% gain.
December 2026
Forecasting for December 2026, models estimate that Akebia Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.78 and $5.63, averaging $5.55. This signals a positive trajectory with potential returns around +333.59%.
January 2027
According to our latest forecast models, Akebia Therapeutics, Inc. (AKBA) is positioned to show a strong performance in January 2027. The price is predicted to move between $1.81 and $5.75, settling at an average of $5.42. This could translate to a +323.44% gain.
February 2027
Based on current market signals, Akebia Therapeutics, Inc. is projected to trend february 2027. We forecast a trading range from $0.55 to $6.08, with a likely average price of $5.45. Investors could expect a potential return of +325.78%.
March 2027
Our predictive algorithms indicate Akebia Therapeutics, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$5.19, with an average target of $4.63. This represents a positive outlook and a possible gain of +261.72%.
April 2027
Analyzing established trends, Akebia Therapeutics, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $5.06, averaging around $3.75. This suggests a +192.97% gain from current levels.
May 2027
Market indicators suggest Akebia Therapeutics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $5.54, with a midpoint forecast of $3.95. The stock might deliver a +208.59% gain.
June 2027
Forecasting for June 2027, models estimate that Akebia Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $6.10, averaging $4.18. This signals a positive trajectory with potential returns around +226.56%.
July 2027
According to our latest forecast models, Akebia Therapeutics, Inc. (AKBA) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $7.86, settling at an average of $4.99. This could translate to a +289.84% gain.
AKBA's history of dividends and stock splits also plays a role in long-term investor confidence.